Asthma drug limits serious reactions to allergy-triggering foods, study says Feb. 26, 2024 Heather Cassell, MD, commented on a new study that says omalizumab, a drug approved to treat allergic asthma and chronic hives, can limit children’s dangerous allergic responses to small amounts of allergy-triggering foods. UPI
Soto’s mission is improving well-being of migrant farmworkers Feb. 26, 2024 Public Health professor grew up working in the fields alongside her parents and now works to help people like them. Read more Image
Starren named biomedical informatics, biostatistics director Feb. 26, 2024 Former Northwestern University director of the Center for Biomedical Informatics and Data Science brings extensive teaching and research background to Health Sciences. Read more
Researchers awarded $3M NIH grant to study new therapies for lung diseases in premature babies Feb. 23, 2024 The grant will support the development of innovative treatments for bronchopulmonary dysplasia, a severe complication for premature infants. Read more Image
Can green light therapy help migraines? Feb. 23, 2024 Research from the UArizona Health Sciences Comprehensive Center for Pain & Addiction found that green light therapy may provide benefits in the treatment of recurrent migraines. Health Central
$3M grant awarded to develop new therapy for lung diseases in preemies Feb. 23, 2024 Vlad Kalinichenko, MD, PhD, director of the Phoenix Children's Research Institute and professor of child health at the College of Medicine – Phoenix, received a $3 million grant from the National Heart, Lung and Blood Institute to develop new treatment methods for lung disease in premature infants. Respiratory Therapy
The Buckmaster Show 2/21/2024 Feb. 22, 2024 Victoria Maizes, MD, executive director of the Andrew Weil Center for Integrative Medicine in the College of Medicine – Tucson, is interviewed about topics including the health benefits of staying active. KVOI-Radio (Tucson, AZ)
Scottsdale-based HonorHealth to offer T cell immune therapy Feb. 22, 2024 HonorHealth Research Institute plans to offer the T cell therapy lifileucel to treat melanoma that cannot be surgically removed or that has spread to other parts of the body. The product is the first T cell immunotherapy to receive FDA approval for a solid tumor cancer. Scottsdale Independent (Scottsdale, AZ)